Gastroesophageal Reflux  >>  dexlansoprazole  >>  Phase 1
Welcome,         Profile    Billing    Logout  

4 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
dexlansoprazole / Generic mfg.
NCT00847210: Pharmacokinetic and Safety of Dexlansoprazole in Adolescents With Gastroesophageal Reflux Disease

Completed
1
36
US
Dexlansoprazole MR, TAK-390MR, Kapidex, Dexilant
Takeda
Gastroesophageal Reflux
09/09
09/09
NCT01045096: Study to Evaluate the Pharmacokinetics and Safety of Dexlansoprazole in Pediatric Subjects With Symptomatic Gastroesophageal Reflux Disease

Completed
1
36
US
Dexlansoprazole, Kapidex, TAK-390MR, Dexilant
Takeda
Gastroesophageal Reflux
02/11
02/11
NCT01149395: Can E-cadherin Found in Tissue/Blood be Valuable in Identifying & Monitoring Patients With Post-proton Pump Inhibitor (PPI)-Responsive Heartburn

Completed
1
40
US
Dexlansoprazole, Kapidex
University of North Carolina, Chapel Hill
Heartburn, Gastroesophageal Reflux Disease
04/12
04/12
NCT02096458: Sensory Evaluation of Dexlansoprazole Delayed-Release Orally Disintegrating Tablets

Completed
1
8
US
Dexlansoprazole
Takeda
Gastroesophageal Reflux Disease, Erosive Esophagitis, Heartburn
02/14
02/14

Download Options